NASDAQ: VCNX - Vaccinex, Inc.

六个月盈利: -72.6%
股息率: 0.00%
部门: Healthcare

促销时间表 Vaccinex, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Vaccinex, Inc.

Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D. Its Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease.

更多详情
It has also developed ActivMAb, an antibody drug discovery platform based on a novel method for complex targets, such as multi-pass membrane receptors or large and diverse libraries of full-length human monoclonal antibodies on the surface of pox viruses. The company was incorporated in 2001 and is headquartered in Rochester, New York.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2018-08-09
ISIN US9186401033
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.vaccinex.com
Цена ао 0.61
每日价格变化: +52.7% (0.61)
每周价格变化: +63.42% (0.57)
每月价格变化: -26.65% (1.27)
3个月内价格变化: -14.54% (1.09)
六个月内的价格变化: -72.6% (3.4)
每年价格变化: -87.43% (7.41)
3年内价格变化: -33.94% (1.41)
5年内价格变化: -82.36% (5.28)
年初以来价格变化: -4.95% (0.98)
所有参数

低估

姓名 意义 年级
P/S 8.37 1
P/BV -2.06 0
P/E 0 0
EV/EBITDA -0.153 0
全部的: 3.88

效率

姓名 意义 年级
ROA, % -557.73 0
ROE, % 876.29 10
全部的: 3.33

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.0108 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 8.99 2
盈利能力 Ebitda, % -37.51 0
盈利能力 EPS, % 1654.11 10
全部的: 2.4
更多详情

机构 体积 分享, %
AIGH Capital Management LLC 58362 4.74
Worth Venture Partners, LLC 46720 3.79
Vanguard Group Inc 3444 0.28
Renaissance Technologies, LLC 2293 0.19
Two Sigma Investments, LP 1154 0.09
Geode Capital Management, LLC 1150 0.09
XTX Topco Ltd 838 0.07
Tower Research Capital LLC (TRC) 475 0.04
Group One Trading, L.P. 65 0.01
UBS Group AG 24 0



导师 职称 支付 出生年份
Dr. Maurice Zauderer Ph.D. Co-Founder, CEO, President & Director 411.7k 1946 (79 年)
Dr. Elizabeth E. Evans Ph.D. COO and Senior VP of Discovery & Translational Medicine 291.57k 1973 (52 年)
Dr. Ernest S. Smith Ph.D. Senior VP of Research & Chief Scientific Officer 297.25k 1972 (53 年)
Dr. John E. Leonard Ph.D. Senior Vice President of Development N/A 1947 (78 年)
Ms. Jill Sanchez CPA Chief Financial Officer N/A 1972 (53 年)

地址: United States, Rochester. NY, 1895 Mount Hope Avenue - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.vaccinex.com